You are currently browsing the archives for 10 February 2018.
Displaying 1 - 2 of 2 entries.

Apexigen enters collaboration with Centocor R&D for antibody discovery Apexigen.

Apexigen enters collaboration with Centocor R&D for antibody discovery Apexigen, Inc. Announced today that it provides entered right into a collaboration and worldwide permit agreement with Centocor Analysis & Advancement, Inc. And its own affiliates to make use of Apexigen’s proprietary therapeutic antibody technology to find and develop monoclonal antibody drugs medications . Apexigen’s antibody technologies produce a wide diversity of antibodies with high specificity, high affinity, and unique epitopes, and will generate antibodies against challenging antigens where competing technology fail successfully.

The survey also found that while 74 percent of businesses offer paid ill leave for employees.

Only a quarter of businesses could keep up such a strategy for a lot more than 4 weeks.. Business operations to be hit in the event of H1N1 outbreak Employees will face problems as few businesses offer paid leave to care for sick family membersIn a national study of businesses that looks at their preparations for a possible widespread H1N1 outbreak, Harvard School of Public Wellness researchers discovered that only one-third believe they could sustain their business without severe operational problems if half their workforce were absent for 14 days because of H1N1 . Simply one-fifth believe they could avoid such problems for one month with fifty % their workers out. The survey also found that while 74 percent of businesses offer paid ill leave for employees, only 35 percent of businesses provide paid leave that could allow employees to take care of sick family members, and even fewer allows paid period off to care for children if academic institutions/daycares were closed .